Mycobacterium lentiflavum, an emerging pathogen? - 16/08/11
Doi : 10.1016/j.jinf.2005.08.020
Enrico Tortoli a, ⁎ 
, Romano Mattei b, Cristina Russo c, Claudio Scarparo d
, Romano Mattei b, Cristina Russo c, Claudio Scarparo d a Microbiology and Virology Laboratory, Regional Reference Center for Mycobacteria, Careggi Hospital, 50134 Florence, Italy
b Clinical Laboratory, Campo di Marte Hospital, 55100 Lucca, Italy
c Microbiology Laboratory, Ospedale del Bambino Gesù, 00165 Rome, Italy
d Regional Reference Center for Mycobacteria, S. Bortolo Hospital, 36100 Vicenza, Italy
Corresponding author. Address: Centro Regionale di Riferimento per la Diagnostica dei Micobatteri, Piastra dei Servizi, Ospedale di Careggi, viale Morgagni 85, 50134 Firenze, Italy. Tel.: +39 055 4279199; fax: +39 055 4279830.Summary |
Three cases of infection due to Mycobacterium lentiflavum, a recently described species characterized by multiple resistance to anti-mycobacterial drugs, are reported here. While one case simply adds to the number of cervical lynphadenitis reported in literature, the others concern the first isolations from pleural effusions, in a young boy with leukaemia and in an elderly patient with lung disease, respectively.
Le texte complet de cet article est disponible en PDF.Keywords : Mycobacterium lentiflavum, Pleurisy, Lymphadenitis, Case report
Plan
© 2006
The British Infection Society. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 52 - N° 6
P. e185-e187 - juin 2006 Retour au numéro
Article précédent
- Recurrent vacuolar myelopathy in HIV infection
- Kerstin Anneken, Marthe Fischera, Stefan Evers, Stephan Kloska, Ingo-W. Husstedt
- Can boosted atazanavir induce hyperlipotrophy?
- P. Dellamonica
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?